A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

Recruiting

Phase 2

CS-1103A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

Sponsor:

Clear Scientific, Inc.

Code:

NCT06721494

Conditions

Methamphetamine Intoxication

Methamphetamine Disorders

Methamphetamine Abuse

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Methamphetamine

Sterile Saline

CS-1103

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-20. This information was provided to ClinicalTrials.gov by Clear Scientific, Inc. on 2026-01-12.